Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China

References

• PlummerMde MartelCVignatJFerlayJBrayFFranceschiSGlobal burden of cancers attributable to infections in 2012: a synthetic analysisLancet Glob Health201649e609e61627470177
   PubMed Web of Science ®Google Scholar
• GlobocanCervical Cancer estimated incidence, mortality and prevalence worldwide in 2012 Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspxAccessed July 20, 2017
   Google Scholar
• de SanjoséSDiazMCastellsaguéXCliffordGBruniLMuñozNBoschFXWorldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysisLancet Infect Dis20077745345917597569
   PubMed Web of Science ®Google Scholar
• VaccarellaSFranceschiSEngholmGLonnbergSKhanSBrayF50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidenceBr J Cancer2014111596596924992581
   PubMed Web of Science ®Google Scholar
• VaccarellaSLortet-TieulentJPlummerMFranceschiSBrayFWorldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factorsEur J Cancer201349153262327323751569
   PubMed Web of Science ®Google Scholar
• GoodmanAHPV testing as a screen for cervical cancerBMJ2015350h237226126623
   PubMed Web of Science ®Google Scholar
• ArbynMRoncoGAnttilaAEvidence regarding human papillomavirus testing in secondary prevention of cervical cancerVaccine201230Suppl 5F88F9923199969
   PubMed Web of Science ®Google Scholar
• SchiffmanMDoorbarJWentzensenNCarcinogenic human papillomavirus infectionNat Rev Dis Primers201621608627905473
   PubMed Web of Science ®Google Scholar
• RoncoGDillnerJElfströmKEfficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trialsLancet2014383991652453224192252
   PubMed Web of Science ®Google Scholar
• GageJCSchiffmanMKatkiHAReassurance against future risk of precancer and cancer conferred by a negative human papillomavirus testJ Natl Cancer Inst20141068dju15325038467
   PubMedGoogle Scholar
• SchiffmanMDoorbarJWentzensenNCarcinogenic human papillomavirus infectionNat Rev Dis Primers201621608627905473
   PubMed Web of Science ®Google Scholar
• HuhWAultKChelmowDUse of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidanceGynecol Oncol2015136217818225579107
   PubMed Web of Science ®Google Scholar
• DiJRutherfordSChuCReview of the cervical cancer burden and population-based cervical cancer screening in ChinaAsian Pac J Cancer Prev201516177401740726625735
   PubMedGoogle Scholar
• Women’s health in rural ChinaLancet20093749687358
   Google Scholar
• WangRGuoXLWismanGBNationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in ChinaBMC Infect Dis20151525726142044
   PubMed Web of Science ®Google Scholar
• JiangXTangHChenTEpidemiology of gynecologic cancers in ChinaJ Gynecol Oncol2018291e729185265
   PubMed Web of Science ®Google Scholar
• WangBHeMChaoACervical cancer screening among adult women in China, 2010Oncologist201520662763425956407
   PubMed Web of Science ®Google Scholar
• ZhaoFHuSYZhangSWChenWQQiaoYLCervical cancer mortality in 2004–2005 and changes during last 30 years in ChinaZhonghua Yu Fang Yi Xue Za Zhi201044540841220654229
   PubMedGoogle Scholar
• DillnerJReboljMBirembautPLong term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort studyBMJ2008337a175418852164
   PubMed Web of Science ®Google Scholar
• ElfströmKMSmelovVJohanssonALLong term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trialBMJ2014348g13024435414
   PubMed Web of Science ®Google Scholar
• ArbynMSnijdersPJMeijerCJWhich high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?Clin Microbiol Infect201521981782625936581
   PubMed Web of Science ®Google Scholar
• WrightTCStolerMHBehrensCMSharmaAZhangGWrightTLPrimary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening testGynecol Oncol2015136218919725579108
   PubMed Web of Science ®Google Scholar
• BoersAWangRSlagter-MenkemaLClinical validation of the Cervista HPV HR test according to the international guidelines for human papillomavirus test requirements for cervical cancer screeningJ Clin Microbiol201452124391439325297324
   PubMed Web of Science ®Google Scholar
• SolomonDDaveyDKurmanRThe 2001 Bethesda System: terminology for reporting results of cervical cytologyJAMA2002287162114211911966386
   PubMed Web of Science ®Google Scholar
• DaySPHudsonAMastAAnalytical performance of the Investigational Use Only Cervista HPV HR test as determined by a multi-center studyJ Clin Virol200945Suppl 1S63S7219651371
   PubMedGoogle Scholar
• CervistaTM HPV HR. Available from: https://www.hologic.com/sites/default/files/package-insert/15-3100_105_01.pdfAccessed July 20, 2017
   Google Scholar
• WaxmanAGChelmowDDarraghTMLawsonHMoscickiABRevised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervixObstet Gynecol201212061465147123168774
   PubMed Web of Science ®Google Scholar
• MeijerCBerkhofJCastlePEGuidelines for human papilloma-virus DNA test requirements for primary cervical cancer screening in women of 30 years and olderInt J Cancer2009124351652018973271
   PubMed Web of Science ®Google Scholar
• SunPSongYRuanGClinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population studyJ Gynecol Oncol2017285e5028657218
   PubMed Web of Science ®Google Scholar
• PanQJHuSYGuoHQLiquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from ChinaGynecol Oncol2014133217217924631450
   PubMed Web of Science ®Google Scholar
• ASCUS-LSIL Traige Study (ALTS) GroupResults of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significanceAm J Obstet Gynecol200318861383139212824967
   PubMed Web of Science ®Google Scholar
• SaslowDSolomonDLawsonHWAmerican Cancer SocietyAmerican Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerJ Low Genit Tract Dis201216317520422418039
   PubMedGoogle Scholar
• HuhWKAultKAChelmowDUse of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidanceGynecol Oncol2015136217818225579107
   PubMed Web of Science ®Google Scholar
• GoldieSJGaffikinLGoldhaber-FiebertJDCost-effectiveness of cervical-cancer screening in five developing countriesN Engl J Med2005353202158216816291985
   PubMed Web of Science ®Google Scholar